
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2023-2030
Sutures are held in place during wound closure by a medical device known as a suture retention device, often referred to as a wound closure device or suture anchor. It is frequently utilized during surgical operations to speed up the healing of wounds and give the tissues being sutured mechanical support.
The tool aids in ensuring that the sutures stay where they are supposed to be and helps to prevent early sliding or loosening. A small implantable anchor or fastener constructed of biocompatible materials, such as titanium, stainless steel, or bioabsorbable polymers, often serves as the suture retention device. Depending on its intended usage and the particular medical application, the device's design may change.
To make sure the sutures are tightly fixed and retained in place, they are subsequently knotted or linked to the suture retention device.The wound is sealed with sutures, and the healing process gets started. The tool aids in distributing stress along the borders of the wound, lowering the danger of wound dehiscence and fostering effective wound healing.
In several surgical specialities, including general surgery, orthopaedics, plastic surgery, and obstetrics, suture retention devices are frequently utilized. The type of tissue being sutured, the location of the wound, and the surgeon's preference all play a role in the choice of suture retention device and suturing technique.
The use of suture retention devices by healthcare professionals requires appropriate training and skill, as with any medical treatment and technology.
The Global Suture retention device market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.
The HEMIGARD ARS device was utilized to speed up skin closure and reduce dehiscence, according to a case study published by DPM titled "The Use of a Novel Suture Retention Device to Prevent Surgical Wound Dehiscence (SWD)".
The separation of the edges of a closed surgical incision in the skin, with or without the exposure or protrusion of underlying tissue, organs, or implants, is known as surgical wound dehiscence (SWD).After invasive surgical procedures, it can be difficult to re-approximate skin incisions, and SWD is a frequent consequence.
In this case report, the post-surgical skin closure on the left foot included HEMIGARD constructions that transferred tension away from the incision's susceptible region during periods of postoperative edema, preventing incision dehiscence.
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2023-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2023-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2023-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2023-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |